Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA
Holding VNDA?
Track your performance easily

Vanda (VNDA) Ownership - Who Owns Vanda?

418 Followers

Vanda (VNDA) Ownership Overview

29.31%22.63%14.33%33.73%
29.31% Insiders
14.33% Other Institutional Investors
― ETFs
33.73% Public Companies and
Individual Investors
The ownership structure of Vanda (VNDA) stock is a mix of institutional, retail, and individual investors. , 29.31% is owned by Insiders, and 33.73% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 06, 2024
xxxxxxxxxxxxx
$73220
Mar 06, 2024
Mihael Hristos Polymeropoulos
President & Ceo,director,other
xxxxxxxxxxxxx
$231015
Mar 06, 2024
xxxxxxxxxxxxx
$71828
Mar 06, 2024
Kevin Patrick Moran
Svp, Cfo & Treas
xxxxxxxxxxxxx
$63363

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2024
xxxxxxxxxxxxx
$111154

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,992,961Institution5.14%17,718,329
2,814,297Institution4.84%16,660,638
2,595,406Institution4.46%15,364,804
1,871,730Insider3.22%11,080,642
1,103,617Insider1.90%6,533,413
805,336Institution1.38%4,767,589
784,326Institution1.35%4,643,210
675,517Institution1.16%3,999,061
642,200Institution1.10%3,801,824
599,970Institution1.03%3,551,822

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,595,406Institution4.46%15,364,804
805,336Institution1.38%4,767,589
784,326Institution1.35%4,643,210
675,517Institution1.16%3,999,061
642,200Institution1.10%3,801,824
599,970Institution1.03%3,551,822
561,993Institution0.97%3,326,999
463,471Institution0.80%2,743,748
428,328Institution0.74%2,535,702
394,677Institution0.68%2,336,488

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,659,646Institution2.85%8,480,791
1,387,009Institution2.38%8,044,652
870,631Institution1.50%4,448,924
525,937Institution0.90%3,050,435
406,417Institution0.70%2,405,989
266,490Institution0.46%1,545,642
219,171Institution0.38%1,271,192
212,565Institution0.37%1,232,877
199,122Institution0.34%1,178,802
211,592Institution0.36%1,081,235

FAQ

Who Owns Vanda Pharmaceuticals Inc. (VNDA)?
According to the latest TipRanks data, approximately 14.33% of the company's stock is held by institutional investors, 29.31% is held by insiders, and 33.73% is held by retail investors.
    What percentage of Vanda Pharmaceuticals Inc. (VNDA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 14.33% of Vanda Pharmaceuticals Inc. (VNDA) stock is held by institutional investors.
      What percentage of Vanda Pharmaceuticals Inc. (VNDA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.73% of Vanda Pharmaceuticals Inc. (VNDA) stock is held by retail investors.
        Who owns the most shares of Vanda Pharmaceuticals Inc. (VNDA)?
        Vanguard owns the most shares of Vanda Pharmaceuticals Inc. (VNDA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis